Bayesian Capital Management, LP Sesen Bio, Inc. Transaction History

Bayesian Capital Management, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$1.04 - $1.51 $13,000 - $18,875	-12,500 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$0.95 - $2.46 $9,666 - $25,030	-10,175 Reduced 44.87%	12,500 $19,000
Q1 2019 May 14, 2019	BUY	$0.69 - $1.47 $5,985 - $12,752	8,675 Added 61.96%	22,675 $23,000
Q4 2018 Feb 13, 2019	BUY	$0.96 - $2.04 $13,440 - $28,560	14,000 New	14,000 $20,000

Ticker SESN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 201,702,000
Market Cap $127M
Description
Sesen Bio, Inc., a late-stage clinical company, focuses on designing, engineering, developing, and commercializing targeted fusion protein therapeutics (TFPTs) for the treatment patients with cancer. Its lead product candidates include Vicineum, a locally-administered targeted fusion protein that is in Phase III clinical trials for the treatment...

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Bayesian Capital Management, LP with notifications on news.